These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8645110)

  • 1. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus.
    Phillpotts RJ; Venugopal K; Brooks T
    Arch Virol; 1996; 141(3-4):743-9. PubMed ID: 8645110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins.
    Venugopal K; Jiang WR; Gould EA
    Vaccine; 1995 Aug; 13(11):1000-5. PubMed ID: 8525682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody against Saint Louis encephalitis prM viral protein.
    Pupo-Antúnez M; Vázquez S; Sosa AL; Caballero Y; Vásquez Y; Morier L; Álvarez M; Guzmán MG
    J Virol Methods; 2015 Jun; 218():14-8. PubMed ID: 25744380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies.
    Ashok MS; Rangarajan PN
    Vaccine; 1999 Aug; 18(1-2):68-75. PubMed ID: 10501236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool.
    Pugachev KV; Guirakhoo F; Mitchell F; Ocran SW; Parsons M; Johnson BW; Kosoy OL; Lanciotti RS; Roehrig JT; Trent DW; Monath TP
    Am J Trop Med Hyg; 2004 Nov; 71(5):639-45. PubMed ID: 15569798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies.
    Mathews JH; Roehrig JT
    J Immunol; 1984 Mar; 132(3):1533-7. PubMed ID: 6198396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.
    Zhao Z; Wakita T; Yasui K
    J Virol; 2003 Apr; 77(7):4248-60. PubMed ID: 12634382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
    Colombage G; Hall R; Pavy M; Lobigs M
    Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
    Schuh T; Schultz J; Moelling K; Pavlovic J
    Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
    Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus.
    Kroeger MA; McMinn PC
    Arch Virol; 2002 Jun; 147(6):1155-72. PubMed ID: 12111426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-protection between group B arboviruses: resistance in mice to Japanese B encephalitis and St. Louis encephalitis viruses induced by Dengue virus immunization.
    Tarr GC; Hammon WM
    Infect Immun; 1974 May; 9(5):909-15. PubMed ID: 4363234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody prevalence of St. Louis encephalitis virus in avian hosts in Los Angeles, California, 1986.
    McLean RG; Webb JP; Campos EG; Gruwell J; Francy DB; Womeldorf D; Myers CM; Work TH; Jozan M
    J Am Mosq Control Assoc; 1988 Dec; 4(4):524-8. PubMed ID: 2852209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of St. Louis encephalitis virus in South Brazil.
    de Souza Lopes O; de Abreu Sacchetta L; Coimbra TL; Pereira LE
    Am J Trop Med Hyg; 1979 May; 28(3):583-5. PubMed ID: 453451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of antibodies against St. Louis encephalitis virus in various marine birds from Panama].
    Montgomery GG; Lee Mo C; Charity S; Riveiro do Valle MB; Peralta PH
    Rev Med Panama; 1984 Sep; 9(3):212-21. PubMed ID: 6093203
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to St. Louis encephalitis virus in armadillos from southern Florida.
    Day JF; Storrs EE; Stark LM; Lewis AL; Williams S
    J Wildl Dis; 1995 Jan; 31(1):10-4. PubMed ID: 7563416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningoencephalitis caused by the St. Louis encephalitis virus].
    Durlach RA; Astarloa L
    Medicina (B Aires); 1985; 45(4):467-8. PubMed ID: 3022104
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.
    Nass PH; Elkins KL; Weir JP
    J Infect Dis; 1998 Sep; 178(3):611-7. PubMed ID: 9728527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.